GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0007193 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, DRD2, DRD3, DRD4, GRM1, GRM3, GRM5, GRM8 |
12.2993 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, CA12, CA2, CA7, CHRM1, CHRM3, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, F10, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HCAR2, HMGCR, HSD11B1, HSD17B1, HSD17B2, KDR, MET, PPARA, SLC1A1, SLC6A2, SLC6A3, SRC, XDH |
10.4985 |
[BP] GO:0007188 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, DRD2, DRD3, DRD4, GRM1, GRM3, GRM5, GRM8 |
9.2105 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, ESR1, FABP3, FABP4, FDPS, FUT7, HMGCR, HSD11B1, HSD17B1, HSD17B2, MET, PPARA |
8.84653 |
[BP] GO:0007187 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, DRD2, DRD3, DRD4, GRM1, GRM3, GRM5, GRM8 |
8.55673 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, APP, AXL, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, ESR1, FABP3, GRIK5, GRM5, HMGCR, HSD17B2, IGF1R, MMP2, MMP9, PPARA, RORC, SLC6A3, SRC, TYR |
8.46745 |
[BP] GO:0007215 |
None
|
APP, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
8.46745 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FDPS, HMGCR, HSD11B1, HSD17B1, HSD17B2 |
8.46745 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, APP, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, FABP3, FABP4, FLT3, GRIK5, GRM5, HMGCR, HSD17B2, IGF1R, KDR, MMP2, PPARA, RORC, SLC6A3, SRC, TYR |
7.74703 |
[BP] GO:0007268 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
7.74612 |
[BP] GO:0098916 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
7.74612 |
[BP] GO:0099536 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
7.67815 |
[BP] GO:0099537 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
7.67815 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, CA2, CA7, DRD2, DRD3, DRD4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
7.67815 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, CA2, CA7, DRD2, DRD3, DRD4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
7.67815 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, APP, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, FABP3, FABP4, FLT3, GRIK5, GRM5, HMGCR, HSD17B2, IGF1R, KDR, MMP2, MMP9, PPARA, RORC, SLC6A2, SLC6A3, SRC, TYR |
7.20724 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, ALOX5, APP, AXL, CHRM1, CHRM3, CHRM5, CYP19A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, F10, FABP4, GRM1, GRM5, GRM8, HMGCR, HSD17B2, IGF1R, MET, MMP1, MMP2, MMP9, PIM1, PPARA, RORC, SLC6A2, SLC6A3, SRC, TYR |
7.07692 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
7.02009 |
[BP] GO:0007197 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
6.43795 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, FDPS, HMGCR, SLC6A3, TYR |
6.16694 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, DRD4, FABP3, PPARA, SLC1A1 |
6.12735 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, CA2, CA7, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, F10, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HCAR2, HMGCR, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC1A1, SLC6A3, SRC, XDH |
6.07547 |
[BP] GO:0007207 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
6.01699 |
[BP] GO:0014070 |
response to organic cyclic compound
|
APP, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, FLT3, RORC, SLC6A3, SRC, TYR |
5.98762 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, F10, FLT3, GRM1, HCAR2, HMGCR, KDR, MET, MMP9, PTPN1, SRC, XDH |
5.96806 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
5.96381 |
[BP] GO:0007267 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, DRD2, DRD3, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
5.96381 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, F10, FLT3, GRM1, HCAR2, HMGCR, KDR, MET, MMP9, PTPN1, SRC, XDH |
5.96115 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CHRM5, CYP1A1, DRD3, FABP3, FDPS, FLT3, HCAR2, HMGCR, PPARA, RORC, SRC |
5.83786 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, KDR, MMP9, SLC6A3, SRC |
5.70084 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FDPS, FUT7, HMGCR, PIM1, PPARA, TYR, XDH |
5.68953 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, FABP4, GRM3, HMGCR, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC |
5.54124 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, F10, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, IGF1R, KDR, MET, MMP9, PTPN1, SRC, XDH |
5.54124 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, F10, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, IGF1R, KDR, MET, MMP9, PTPN1, SRC, XDH |
5.42824 |
[BP] GO:0023052 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, DRD2, DRD3, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
5.42824 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD17B1, HSD17B2 |
5.32197 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, CA2, CA7, CDC25B, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, F10, FABP3, FLT3, GRIK5, GRM1, GRM5, HCAR2, HMGCR, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, XDH |
5.28993 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, DRD2, ESR1, HCAR2, HMGCR, HSD11B1, HSD17B1, HSD17B2 |
5.28628 |
[BP] GO:0007196 |
None
|
GRM1, GRM3, GRM5, GRM8 |
5.2652 |
[BP] GO:0007200 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, DRD2, ESR1, GRM5 |
5.19484 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, TYR |
5.17103 |
[BP] GO:0007154 |
None
|
ADORA1, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD2, DRD3, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
5.06345 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, DRD4, FABP3, PPARA, SLC1A1 |
4.99637 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, APP, CDC25B, CHRM5, DRD2, DRD3, DRD4, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
4.99453 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, APP, CDC25B, CHRM5, DRD2, DRD3, DRD4, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
4.94398 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM5, DRD2, DRD3, DRD4, FABP3, GRIA2, GRIA4, GRIK5, PPARA, SLC1A1, SLC6A2, SLC6A3 |
4.90767 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, DRD2, GRM1, GRM3, GRM5, GRM8 |
4.84417 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, APP, CDC25B, CHRM1, CSNK2A1, CYP1B1, DRD2, DRD3, ESR1, FABP3, FLT3, HMGCR, IGF1R, KDR, MMP2, MMP9, PIM1, SRC, XDH |
4.77179 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, F10, FLT3, GRM1, HMGCR, IGF1R, KDR, MET, MMP9, PTPN1, SRC, XDH |
4.67601 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, APP, AXL, CA1, CA2, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC |
4.66644 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.64232 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, APP, AXL, CA12, CA2, CA7, DRD2, DRD3, DRD4, ESR1, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, MET, SRC |
4.64232 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, AXL, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, HMGCR, KDR, SLC6A3, SRC |
4.55392 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP3, FABP4, FDPS, FUT7, HMGCR, MET, PPARA |
4.54113 |
[BP] GO:0007216 |
None
|
GRM1, GRM3, GRM5, GRM8 |
4.50775 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AXL, CYP1B1, DRD2, DRD4, F10, FLT3, GRM1, HMGCR, KDR, MET, PTPN1, SRC, XDH |
4.4782 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, CA9, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, FABP3, HMGCR, KDR, SLC6A2, SLC6A3, SRC |
4.43015 |
[BP] GO:1900543 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8, PPARA |
4.43015 |
[BP] GO:0045980 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8, PPARA |
4.40317 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, APP, AXL, CA2, CA7, CHRM1, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, F10, GRIK5, GRM5, HCAR2, HMGCR, IGF1R, KDR, MET, MMP9, PPARA, PTPN1, SRC |
4.35656 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD2, DRD3, DRD4, SLC6A3 |
4.35213 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, APP, CA2, CHRM1, CHRM2, CHRM3, CHRM5, DRD2, DRD3, DRD4, ESR1, GRM1, GRM3, GRM5, GRM8, HCAR2, SRC |
4.33738 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD2, DRD3, DRD4, GRIK5, SLC1A1, SLC6A2, SLC6A3 |
4.33645 |
[BP] GO:0007213 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
4.3077 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, DRD2, DRD3, DRD4, FABP3, FLT3, GRM5, IGF1R, MMP2, PPARA, SLC6A3, SRC, TYR |
4.29915 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, FDPS, HMGCR, HSD11B1, HSD17B1, HSD17B2 |
4.27665 |
[BP] GO:0060078 |
None
|
ADORA1, DRD4, GRIA2, GRIA4, GRIK5, GRM5 |
4.26879 |
[BP] GO:0018958 |
None
|
AKR1B1, DRD2, DRD3, DRD4, SLC6A3, TYR |
4.2395 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, GRIK5, HCAR2, HMGCR, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SRC, XDH |
4.17449 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD2, DRD3, DRD4, SLC6A3 |
4.1381 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD2, DRD3, DRD4, SLC6A3 |
4.1381 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, CA2, CA9, CBR1, CDC25B, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, ESR1, FABP4, FLT3, FUT7, HMGCR, HSD11B1, HSD17B2, KDR, MET, MMP2, MMP9, PIM1, PPARA, RORC, SLC6A3, SRC, TYR |
4.12861 |
[BP] GO:0030818 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
4.10724 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, APP, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, F10, FLT3, GRM1, HMGCR, KDR, MET, MMP9, PTPN1, SRC, XDH |
4.05714 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, GRIK5, HCAR2, HMGCR, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SRC, XDH |
4.03477 |
[BP] GO:0030803 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
4.02497 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AURKB, AXL, CA2, CA9, CHRM2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, F10, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HMGCR, HSD17B2, IGF1R, KDR, MMP2, MMP9, PPARA, PTPN1, RORC, SLC6A2, SLC6A3, SRC, TYR |
4.02497 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, DRD2, DRD3, DRD4, ESR1, PPARA, RORC, SRC |
4.02114 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, APP, CA12, CA2, CA7, DRD2, DRD3, DRD4, ESR1, FABP3, FABP4, GRIK5, GRM1, GRM5, MET |
4.00935 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, DRD2, DRD3, DRD4, FABP3, FLT3, GRM5, IGF1R, MMP2, PPARA, SLC6A3, SRC, TYR |
3.97534 |
[BP] GO:0030815 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
3.95943 |
[BP] GO:1900372 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
3.92095 |
[BP] GO:0030809 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
3.92095 |
[BP] GO:0030800 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
3.87985 |
[BP] GO:0033993 |
response to lipid
|
AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, ESR1, FABP3, FLT3, HSD17B2, RORC, SRC, TYR |
3.8453 |
[BP] GO:0042752 |
None
|
ADORA1, DRD2, DRD3, DRD4, PPARA, RORC |
3.75556 |
[BP] GO:0095500 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.75556 |
[BP] GO:1903831 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.75556 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, APP, DRD2, DRD4, FLT3, GRM1, HMGCR, KDR, PTPN1, SRC, XDH |
3.71991 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.68796 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AURKB, AXL, CA1, CA12, CA2, CA7, CA9, CDC25B, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, F10, FABP3, FABP4, FDPS, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD11B1, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A3, SRC, XDH |
3.68796 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, CDC25B, CHRM1, CSNK2A1, DRD2, DRD3, ESR1, FLT3, HMGCR, IGF1R, KDR, MMP2, MMP9, PIM1 |
3.65121 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, APP, AXL, CA1, CSNK2A1, DRD2, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
3.62616 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APP, CHRM1, CYP19A1, CYP1B1, DRD2, DRD3, F10, IGF1R, KDR, MET, MMP9, SRC |
3.62616 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, CBR1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, SLC6A3 |
3.60898 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HMGCR, HSD11B1, HSD17B1, HSD17B2, TYR, XDH |
3.60381 |
[BP] GO:0035235 |
None
|
APP, GRIA2, GRIA4, GRIK5 |
3.57285 |
[BP] GO:0046903 |
None
|
ALOX5, APP, AXL, CA2, CA9, CHRM1, CHRM3, CHRM5, DRD2, DRD3, DRD4, MMP9, SLC1A1, SLC6A3, XDH |
3.56159 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, CHRM1, CHRM3, CHRM5, CYP1A1, ESR1, FLT3, MET, PIM1, SRC, TYR |
3.53917 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, GRIK5, HCAR2, HMGCR, IGF1R, KDR, MMP9, PIM1, PTPN1, SRC, XDH |
3.53855 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD17B1, HSD17B2 |
3.51925 |
[BP] GO:0007271 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.51925 |
[BP] GO:0051940 |
None
|
DRD2, DRD3, DRD4 |
3.5172 |
[BP] GO:0051584 |
None
|
DRD2, DRD3, DRD4 |
3.5172 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, APP, CDC25B, DRD2, DRD4, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, PTPN1, SRC |
3.4977 |
[BP] GO:0042417 |
None
|
DRD2, DRD3, DRD4, SLC6A3 |
3.47628 |
[BP] GO:0007626 |
None
|
APP, DRD2, DRD3, DRD4, GRM1, GRM5, SLC6A3 |
3.44968 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, APP, AXL, CA2, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, ESR1, FLT3, HSD11B1, HSD17B2, KDR, MMP9, PIM1, PPARA, RORC, SLC6A3, SRC, TYR |
3.44968 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, F10, FABP3, FABP4, FDPS, FLT3, FUT7, HMGCR, HSD11B1, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC6A3, SRC, TYR, XDH |
3.38278 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, APP, CDC25B, DRD2, DRD4, FLT3, GRM1, GRM5, HMGCR, KDR, MMP9, PTPN1, SRC, XDH |
3.38278 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, HMGCR, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SRC |
3.36717 |
[BP] GO:0015908 |
None
|
DRD2, DRD3, DRD4, FABP3, PPARA |
3.36717 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, DRD2, DRD4 |
3.34 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, APP, CDC25B, DRD2, DRD4, FABP3, FLT3, GRM1, GRM5, HMGCR, KDR, MMP9, PTPN1, SRC, XDH |
3.34 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, APP, CDC25B, DRD2, DRD4, FABP3, FLT3, GRM1, GRM5, HMGCR, KDR, MMP9, PTPN1, SRC, XDH |
3.34 |
[BP] GO:0007194 |
None
|
DRD2, DRD3, DRD4, GRM3 |
3.27855 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7, DRD2 |
3.27855 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, FDPS, HMGCR |
3.26605 |
[BP] GO:0007195 |
None
|
DRD2, DRD3, DRD4 |
3.25486 |
[BP] GO:2001225 |
regulation of chloride transport
|
CA2, CA7, GRM5 |
3.25486 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.25486 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, CA2, CA7, DRD2, DRD3, HCAR2, HMGCR, KDR, SRC |
3.2546 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
3.24304 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, APP, CA2, CA9, CSNK2A1, CYP1A2, ESR1, FABP3, FLT3, GRM5, IGF1R, MMP2, PPARA, SRC |
3.23452 |
[BP] GO:0045936 |
None
|
DRD2, DRD3, DRD4, FABP4, GRM3, GRM8, HMGCR, IGF1R, PPARA, PTPN1, XDH |
3.23341 |
[BP] GO:0010563 |
None
|
DRD2, DRD3, DRD4, FABP4, GRM3, GRM8, HMGCR, IGF1R, PPARA, PTPN1, XDH |
3.22885 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, F10, FABP3, FABP4, FDPS, FLT3, FUT7, HMGCR, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP2, PIM1, PPARA, PTPN1, RORC, SLC6A3, SRC, TYR, XDH |
3.22467 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, APP, DRD2, DRD4, FLT3, GRM1, HMGCR, IGF1R, KDR, PTPN1, SRC, XDH |
3.22467 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, APP, CDC25B, DRD2, DRD4, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, PTPN1, SRC |
3.22467 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, APP, CDC25B, DRD2, DRD4, FLT3, GRM1, GRM5, HMGCR, KDR, MMP9, PTPN1, SRC, XDH |
3.2185 |
[BP] GO:0031280 |
None
|
DRD2, DRD3, DRD4, GRM3 |
3.20429 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, CA2, CYP1A1, DRD2, DRD3, GRM1, HMGCR, MMP2, PPARA, SRC, TYR |
3.15325 |
[BP] GO:0034776 |
None
|
DRD2, DRD3, DRD4 |
3.14627 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, HMGCR, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SRC |
3.12705 |
[BP] GO:0046717 |
None
|
CHRM5, DRD2, DRD3, DRD4, SLC1A1 |
3.12637 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, APP, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, F10, FABP4, FLT3, GRM1, HMGCR, KDR, MET, MMP2, MMP9, PTPN1, SRC, XDH |
3.12566 |
[BP] GO:0051350 |
None
|
DRD2, DRD3, DRD4, GRM3 |
3.11645 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, CA2, CA7, DRD2, DRD3, KDR, SRC |
3.11024 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, APP, AURKB, CDC25B, DRD2, DRD4, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, PTPN1, SRC |
3.11024 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, APP, AXL, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, GRIK5, GRM5, IGF1R, KDR, MMP2, MMP9, RORC, SRC |
3.09163 |
[BP] GO:0032467 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
3.07916 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, DRD3, F10, MET, SRC, XDH |
3.07916 |
[BP] GO:0015872 |
None
|
CHRM5, SLC6A2, SLC6A3 |
3.04935 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, AXL, CYP1B1, ESR1, GRIK5, GRM5, IGF1R, MMP2, MMP9, RORC, SRC |
3.04935 |
[BP] GO:0042391 |
None
|
ADORA1, APP, DRD4, GRIA2, GRIA4, GRIK5, GRM5, KDR, SRC |
3.04785 |
[BP] GO:0050878 |
regulation of body fluid levels
|
ADORA1, AKR1B1, CHRM1, CHRM3, DRD2, F10, MET, SLC6A3, XDH |
3.04785 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, APP, CDC25B, DRD2, DRD4, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
3.04027 |
[BP] GO:0050877 |
None
|
ADORA1, APP, CHRM1, CHRM5, CYP1B1, DRD2, DRD3, GRM1, GRM5, GRM8, HMGCR, SLC6A3, TYR |
3.03732 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, FLT3, HSD11B1, HSD17B2, KDR, PPARA, SRC, TYR |
3.0353 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, APP, AXL, CA2, CA7, CHRM1, CYP19A1, DRD2, DRD3, DRD4, GRIK5, GRM5, HCAR2, HMGCR, MMP9, PPARA, PTPN1, SRC |
3.01463 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
DRD2, DRD3, ESR1, HMGCR, IGF1R, MET, MMP9, PTPN1, SRC, XDH |
3.00411 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, CHRM1, CHRM2, CHRM3, DRD2, DRD3, GRM1, HCAR2, SLC1A1 |
2.99159 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APP, CYP19A1, CYP1B1, DRD2, F10, IGF1R, KDR, MET, MMP9, SRC |
2.96373 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.96373 |
[BP] GO:0060134 |
None
|
DRD2, DRD3, SLC6A3 |
2.96373 |
[BP] GO:0006810 |
None
|
ACHE, ADORA1, ALOX5, APP, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM1, CHRM3, CHRM5, DRD2, DRD3, DRD4, F10, FABP3, GRIA2, GRIA4, GRIK5, MMP9, PPARA, SLC1A1, SLC6A2, SLC6A3, SRC, XDH |
2.95167 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, APP, AXL, CYP1A1, CYP1B1, ESR1, FABP4, FLT3, GRIK5, GRM5, IGF1R, KDR, MMP2, RORC, SRC |
2.92843 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX5, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, F10, FABP3, FABP4, FDPS, FLT3, FUT7, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A3, SRC, TYR, XDH |
2.92235 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, APP, CDC25B, DRD2, DRD4, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MMP9, PTPN1, SRC, XDH |
2.9182 |
[BP] GO:0045776 |
None
|
ADORA1, DRD2, DRD3, PPARA |
2.90772 |
[BP] GO:0010038 |
response to metal ion
|
APP, CA2, CYP1A1, CYP1A2, DRD2, FABP4, MMP9, SLC6A3 |
2.90772 |
[BP] GO:0003008 |
None
|
ADORA1, AKR1B1, APP, CHRM1, CHRM3, CHRM5, CYP1B1, DRD2, DRD3, GRM1, GRM5, GRM8, HMGCR, SLC6A3, SRC, TYR |
2.89858 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.88579 |
[BP] GO:0051580 |
None
|
DRD2, DRD3, DRD4 |
2.88579 |
[BP] GO:0050801 |
ion homeostasis
|
APP, CA12, CA2, CA7, DRD2, DRD3, DRD4, ESR1, FABP3, GRM1, GRM5 |
2.83517 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, APP, AURKB, CDC25B, CSNK2A1, DRD2, DRD3, DRD4, ESR1, FABP4, FLT3, GRM1, GRM3, GRM5, HMGCR, IGF1R, MMP9, PTPN1, SRC, XDH |
2.83113 |
[BP] GO:0051234 |
None
|
ACHE, ADORA1, ALOX5, APP, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM1, CHRM3, CHRM5, DRD2, DRD3, DRD4, F10, FABP3, GRIA2, GRIA4, GRIK5, MMP9, PPARA, SLC1A1, SLC6A2, SLC6A3, SRC, XDH |
2.81079 |
[BP] GO:0051179 |
None
|
ACHE, ADORA1, ALOX5, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM1, CHRM3, CHRM5, DRD2, DRD3, DRD4, ESR1, F10, FABP3, GRIA2, GRIA4, GRIK5, MMP9, PPARA, SLC1A1, SLC6A2, SLC6A3, SRC, XDH |
2.8088 |
[BP] GO:0045761 |
None
|
DRD2, DRD3, DRD4, GRM3 |
2.80565 |
[BP] GO:0051937 |
None
|
CHRM5, SLC6A2, SLC6A3 |
2.80319 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, FDPS, HMGCR, HSD11B1, HSD17B1, HSD17B2 |
2.80012 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, APP, CA2, CHRM1, DRD2, DRD3, DRD4, HCAR2, HMGCR, PTPN1, SRC |
2.79012 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, CYP19A1, FDPS, HMGCR, SLC6A3, TYR |
2.75951 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APP, CYP19A1, CYP1B1, DRD2, F10, IGF1R, KDR, MET, MMP9, SRC |
2.74019 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, DRD4, FLT3, GRM1, HMGCR, IGF1R, PTPN1, SRC |
2.74019 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1 |
2.73901 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.73233 |
[BP] GO:0032225 |
None
|
DRD2, DRD3, DRD4 |
2.73233 |
[BP] GO:0030817 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
2.72278 |
[BP] GO:0008542 |
None
|
APP, DRD2, DRD3, HMGCR |
2.71674 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, APP, AURKB, CDC25B, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, FABP4, FLT3, GRM1, GRM3, GRM5, HMGCR, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC, XDH |
2.6913 |
[BP] GO:0001504 |
None
|
SLC1A1, SLC6A2, SLC6A3 |
2.65966 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1 |
2.60851 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, HMGCR, IGF1R, KDR, MMP9, PIM1, PTPN1, SRC |
2.59815 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, PIM1, PPARA, RORC, SRC |
2.59689 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, MMP1, MMP2, MMP9, SLC6A3, SRC, XDH |
2.59375 |
[BP] GO:0007632 |
None
|
APP, DRD2, DRD3, HMGCR |
2.56387 |
[BP] GO:0015909 |
None
|
DRD2, DRD3, DRD4, FABP3 |
2.56387 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, FDPS |
2.56097 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, SRC |
2.55012 |
[BP] GO:0099566 |
None
|
GRM1, GRM5 |
2.55012 |
[BP] GO:0051944 |
None
|
DRD2, DRD4 |
2.55012 |
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.55012 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.55012 |
[BP] GO:0051586 |
None
|
DRD2, DRD4 |
2.55012 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CBR1, CYP1A1, CYP1A2, CYP1B1 |
2.54983 |
[BP] GO:0045187 |
None
|
ADORA1, DRD2, DRD3 |
2.54456 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, APP, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, GRIK5, GRM1, GRM5, IGF1R, KDR, MMP2, MMP9, PTPN1, RORC, SRC |
2.53311 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
2.53097 |
[BP] GO:0032922 |
None
|
DRD2, DRD3, PPARA, RORC |
2.53097 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, APP, CA2, CA7, CHRM1, DRD2, DRD3, DRD4, GRM5, MMP9 |
2.51464 |
[BP] GO:0050890 |
None
|
ADORA1, APP, CHRM1, DRD2, DRD3, GRM5, HMGCR |
2.51403 |
[BP] GO:0043086 |
negative regulation of catalytic activity
|
APP, CSNK2A1, DRD2, DRD3, DRD4, FABP4, GRM3, HMGCR, IGF1R, MMP9, PTPN1, SRC |
2.49663 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.49098 |
[BP] GO:0048148 |
None
|
DRD2, DRD3, DRD4 |
2.49096 |
[BP] GO:0035813 |
None
|
ADORA1, DRD2, DRD3 |
2.49096 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APP, CYP19A1, CYP1B1, DRD2, F10, IGF1R, KDR, MET, MMP9, SRC |
2.46026 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
APP, AXL, CA2, CHRM3, CYP1B1, DRD2, DRD3, HCAR2, HMGCR, KDR, MET, MMP9, PIM1, SLC1A1, SLC6A3, SRC |
2.4599 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.4599 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD2, DRD3, HMGCR, PPARA, SLC6A3 |
2.45643 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
2.44057 |
[BP] GO:0030814 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
2.44057 |
[BP] GO:0015844 |
None
|
CHRM5, SLC6A2, SLC6A3 |
2.43998 |
[BP] GO:0042749 |
None
|
ADORA1, DRD2, DRD3 |
2.43998 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.43998 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, APP, CDC25B, DRD2, DRD4, FLT3, GRM1, GRM5, HMGCR, KDR, MMP9, PTPN1, SRC, XDH |
2.43998 |
[BP] GO:1903522 |
None
|
ADORA1, ADORA3, CHRM1, CHRM2, CHRM3, DRD2, SLC1A1 |
2.41004 |
[BP] GO:0030802 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
2.39805 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.38488 |
[BP] GO:0031279 |
None
|
DRD2, DRD3, DRD4, GRM3 |
2.38488 |
[BP] GO:0051339 |
None
|
DRD2, DRD3, DRD4, GRM3 |
2.3585 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, CDC25B, DRD2, DRD4, FLT3, GRM1, GRM5, PTPN1, SRC |
2.35838 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
APP, CA12, CA2, CA7, DRD2, DRD3, DRD4, ESR1, GRM1, GRM5 |
2.35127 |
[BP] GO:0098657 |
import into cell
|
ACHE, ADORA1, APP, AXL, DRD2, DRD3, SLC1A1, SLC6A2, SLC6A3 |
2.34832 |
[BP] GO:1903963 |
None
|
DRD2, DRD3, DRD4 |
2.337 |
[BP] GO:0044062 |
None
|
ADORA1, DRD2, DRD3 |
2.337 |
[BP] GO:0050482 |
None
|
DRD2, DRD3, DRD4 |
2.337 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.337 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD2, DRD3, ESR1, FABP4, HMGCR, KDR, MET, PPARA, SLC6A3 |
2.33452 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA |
2.32535 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, APP, AXL, CA2, CHRM1, CHRM2, CHRM3, CYP1B1, DRD2, DRD3, ESR1, GRM1, HCAR2, HMGCR, KDR, MET, MMP9, PIM1, SLC1A1, SLC6A3, SRC, XDH |
2.32465 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.31932 |
[BP] GO:0051582 |
None
|
DRD2, DRD4 |
2.31932 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.31932 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
APP, CA2, CA7, DRD2, DRD3, DRD4, ESR1, GRIK5, GRM1, GRM5 |
2.30975 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, MET, MMP9, PPARA, SRC |
2.3075 |
[BP] GO:0022600 |
None
|
CHRM1, CHRM3, CHRM5, DRD3 |
2.30466 |
[BP] GO:0006940 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3 |
2.30466 |
[BP] GO:0008299 |
None
|
CYP1A1, FDPS, HMGCR |
2.29962 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.29962 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, CA2, CA9, CSNK2A1, CYP1A2, ESR1, FABP3, FLT3, PPARA, SRC |
2.28552 |
[BP] GO:0016125 |
None
|
APP, CYP19A1, CYP1B1, FDPS, HMGCR |
2.28552 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, APP, AURKB, CSNK2A1, DRD2, DRD3, DRD4, ESR1, ESR2, FABP4, GRM3, GRM8, HCAR2, HMGCR, IGF1R, KDR, MET, MMP9, PPARA, PTPN1, RORC, SRC, XDH |
2.27219 |
[BP] GO:1900371 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
2.27219 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, APP, AURKB, CDC25B, CSNK2A1, DRD2, DRD3, DRD4, ESR1, ESR2, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MET, MMP9, PPARA, PTPN1, RORC, SRC, XDH |
2.26581 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
APP, DRD2, DRD3, SLC6A3 |
2.2652 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, PPARA, RORC, SRC |
2.26164 |
[BP] GO:0030808 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
2.26164 |
[BP] GO:0048169 |
None
|
APP, DRD2, GRM5 |
2.25861 |
[BP] GO:0032465 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
2.24629 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, APP, CDC25B, CSNK2A1, DRD2, DRD4, ESR1, FLT3, GRM1, GRM5, HMGCR, KDR, MMP9, PTPN1, SRC, XDH |
2.24629 |
[BP] GO:0007610 |
None
|
APP, DRD2, DRD3, DRD4, GRM1, GRM5, HMGCR, PPARA, SLC6A3 |
2.23993 |
[BP] GO:0015718 |
None
|
DRD2, DRD3, DRD4, FABP3, PPARA |
2.23684 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, HMGCR |
2.22832 |
[BP] GO:0060079 |
None
|
ADORA1, GRIA2, GRIA4, GRIK5 |
2.22832 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, APP, AXL, CA2, CHRM1, CYP19A1, DRD2, DRD3, DRD4, HCAR2, SRC |
2.22275 |
[BP] GO:0032309 |
None
|
DRD2, DRD3, DRD4 |
2.21947 |
[BP] GO:0001975 |
None
|
DRD2, DRD3, DRD4 |
2.21947 |
[BP] GO:0007589 |
None
|
CHRM1, CHRM3, SLC6A3, XDH |
2.21031 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, CDC25B, DRD2, DRD4, FLT3, GRM1, GRM5, PTPN1, SRC |
2.20427 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, AKR1B1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, F10, FABP4, FLT3, GRM1, HMGCR, IGF1R, KDR, MET, MMP2, MMP9, PPARA, PTPN1, SLC6A3, SRC, XDH |
2.19754 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, DRD4, GRIK5, HCAR2, HMGCR, SRC |
2.19352 |
[BP] GO:0008306 |
None
|
APP, DRD2, DRD3, HMGCR |
2.19226 |
[BP] GO:0007612 |
None
|
APP, DRD2, DRD3, GRM5, HMGCR |
2.19226 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, AURKB, CDC25B, DRD2, DRD4, FLT3, GRM1, GRM5, PTPN1, SRC |
2.18328 |
[BP] GO:1904646 |
cellular response to amyloid-beta
|
APP, GRM5, IGF1R |
2.18328 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
CHRM5, FABP3, FLT3, SRC |
2.17574 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, FABP3, FABP4, GRM3, GRM8, HCAR2, HMGCR, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, RORC, SLC6A3, SRC, XDH |
2.17574 |
[BP] GO:0032412 |
None
|
APP, DRD2, DRD3, DRD4, GRM5, MMP9 |
2.16791 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, FABP3, FABP4, GRM3, GRM8, HMGCR, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, XDH |
2.16231 |
[BP] GO:0046541 |
None
|
CHRM1, CHRM3 |
2.15816 |
[BP] GO:0090325 |
None
|
DRD2, DRD3 |
2.15816 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.15816 |
[BP] GO:0030534 |
None
|
APP, DRD2, DRD3, DRD4, PPARA |
2.15143 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, CYP19A1, DRD2, DRD3, ESR1, ESR2, HMGCR, IGF1R, MET, MMP9, PPARA, PTPN1, SLC6A3, SRC, XDH |
2.14506 |
[BP] GO:0061097 |
None
|
ADORA1, APP, GRM5, PTPN1 |
2.14457 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, DRD2, DRD3, DRD4, MMP9 |
2.14168 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD2, DRD3, HCAR2 |
2.13998 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, APP, AURKB, CDC25B, DRD2, DRD3, DRD4, ESR1, ESR2, FABP3, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MET, MMP9, PPARA, PTPN1, RORC, SRC, XDH |
2.13252 |
[BP] GO:0030799 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
2.13082 |
[BP] GO:0032413 |
None
|
DRD2, DRD3, DRD4, MMP9 |
2.12782 |
[BP] GO:0030003 |
cellular cation homeostasis
|
APP, CA2, CA7, DRD2, DRD3, DRD4, ESR1, GRM1, GRM5 |
2.1265 |
[BP] GO:0022898 |
None
|
APP, DRD2, DRD3, DRD4, GRM5, MMP9 |
2.12499 |
[BP] GO:0050789 |
regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AURKB, AXL, CA1, CA2, CA7, CA9, CDC25B, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, F10, FABP3, FABP4, FDPS, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC1A1, SLC6A3, SRC, XDH |
2.12211 |
[BP] GO:0071715 |
None
|
DRD2, DRD3, DRD4 |
2.11881 |
[BP] GO:1901571 |
None
|
DRD2, DRD3, DRD4 |
2.11881 |
[BP] GO:0051952 |
None
|
ADORA1, DRD2, DRD3, DRD4 |
2.11566 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, HMGCR, MMP2, MMP9 |
2.11566 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, APP, AURKB, CDC25B, CSNK2A1, DRD2, DRD3, DRD4, ESR1, ESR2, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MET, MMP9, PPARA, PTPN1, RORC, SRC, XDH |
2.11566 |
[BP] GO:0050730 |
None
|
ADORA1, APP, FLT3, GRM5, PTPN1, SRC |
2.1033 |
[BP] GO:1901661 |
None
|
AKR1B1, AKR1B10, HMGCR |
2.08216 |
[BP] GO:1904645 |
response to amyloid-beta
|
APP, GRM5, IGF1R |
2.08216 |
[BP] GO:1900542 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8, PPARA |
2.07734 |
[BP] GO:0002791 |
None
|
ACHE, ADORA1, DRD2, DRD3, DRD4, HCAR2, HMGCR, SRC |
2.07544 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, APP, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, F10, FLT3, GRM1, HMGCR, IGF1R, KDR, MET, MMP9, PTPN1, SRC, XDH |
2.07446 |
[BP] GO:0015893 |
None
|
CA2, CHRM5, SLC1A1, SLC6A2, SLC6A3 |
2.06732 |
[BP] GO:0006873 |
cellular ion homeostasis
|
APP, CA2, CA7, DRD2, DRD3, DRD4, ESR1, GRM1, GRM5 |
2.06638 |
[BP] GO:0042220 |
None
|
DRD2, DRD3, SLC6A3 |
2.04916 |
[BP] GO:0045744 |
None
|
DRD2, DRD3, MET |
2.04916 |
[BP] GO:0010039 |
response to iron ion
|
CYP1A1, DRD2, SLC6A3 |
2.04916 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, APP, CDC25B, DRD2, DRD4, ESR1, FLT3, GRM1, GRM5, HMGCR, KDR, MMP9, PTPN1, SRC, XDH |
2.035 |
[BP] GO:0032415 |
None
|
DRD3, DRD4 |
2.03121 |
[BP] GO:0051934 |
None
|
SLC6A2, SLC6A3 |
2.03121 |
[BP] GO:0021984 |
None
|
DRD2, SLC6A3 |
2.03121 |
[BP] GO:0090494 |
None
|
SLC6A2, SLC6A3 |
2.03121 |
[BP] GO:0090493 |
None
|
SLC6A2, SLC6A3 |
2.03121 |
[BP] GO:0051583 |
None
|
SLC6A2, SLC6A3 |
2.03121 |
[BP] GO:0006140 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8, PPARA |
2.02888 |
[BP] GO:0098801 |
None
|
ADORA1, DRD2, DRD3 |
2.02129 |
[BP] GO:0032409 |
None
|
APP, DRD2, DRD3, DRD4, GRM5, MMP9 |
2.02129 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, APP, AURKB, CA9, CDC25B, CHRM5, CSNK2A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, FABP3, FABP4, FDPS, FLT3, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, RORC, SLC6A3, SRC, XDH |
2.01914 |
[BP] GO:0044070 |
regulation of anion transport
|
ADORA1, CA2, CA7, GRM5 |
2.01914 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, DRD4, GRIK5, HCAR2, HMGCR, SRC |
2.00656 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APP, FABP3, GRM5, IGF1R, PPARA, SRC |
2.00535 |
[BP] GO:0032410 |
None
|
DRD2, DRD3, DRD4, MMP9 |
2.00307 |
[BP] GO:1904063 |
None
|
DRD2, DRD3, DRD4, MMP9 |
2.00307 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1 |
2.00302 |
[BP] GO:0003018 |
None
|
ADORA1, CHRM1, CHRM3, HMGCR, SRC |
2.00302 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, APP, AXL, CA4, CHRM1, CHRM2, CHRM3, CHRM5, DRD2, DRD3, DRD4, F10, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, SLC1A1, SLC6A2, SLC6A3 |
8.2152 |
[CC] GO:0044456 |
None
|
ACHE, ADORA1, APP, CHRM1, CHRM2, CHRM3, CHRM5, DRD2, DRD4, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, SLC6A3, SRC |
7.83403 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, APP, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD2, DRD3, DRD4, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, SLC1A1, SLC6A2, SLC6A3 |
7.13554 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, APP, AXL, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, DRD2, DRD3, DRD4, ESR1, F10, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, MMP2, PIM1, PTPN1, SLC1A1, SLC6A2, SLC6A3, SRC |
6.8001 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, MET, SLC1A1, SRC |
6.60683 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, APP, AXL, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, DRD2, DRD3, DRD4, F10, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, SLC1A1, SLC6A2, SLC6A3, SRC |
6.50828 |
[CC] GO:0097060 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
5.82731 |
[CC] GO:0043005 |
None
|
ADORA1, APP, CA2, CHRM1, CHRM2, CHRM3, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, SLC6A2, SLC6A3, SRC |
5.54124 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, APP, AXL, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, F10, FLT3, FUT7, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD11B1, HSD17B2, IGF1R, KDR, MET, PTPN1, SLC1A1, SLC6A2, SLC6A3, SRC, TYR |
5.02379 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ALOX5, APP, AXL, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, F10, FLT3, FUT7, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD11B1, HSD17B2, IGF1R, KDR, MET, MMP2, PIM1, PTPN1, SLC1A1, SLC6A2, SLC6A3, SRC, TYR |
4.94825 |
[CC] GO:0098793 |
None
|
ADORA1, APP, CHRM1, CHRM2, CHRM3, DRD2, GRIK5, SLC6A3 |
4.60054 |
[CC] GO:0014069 |
None
|
ADORA1, CHRM1, DRD2, GRIK5, GRM1, GRM3, GRM5, SRC |
4.12861 |
[CC] GO:0099572 |
None
|
ADORA1, CHRM1, DRD2, GRIK5, GRM1, GRM3, GRM5, SRC |
4.12861 |
[CC] GO:0042995 |
cell projection
|
ADORA1, AKR1B1, APP, CA2, CHRM1, CHRM2, CHRM3, DRD2, DRD3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, SLC6A2, SLC6A3, SRC |
3.97534 |
[CC] GO:0045211 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, GRIA2, GRIA4, GRIK5, GRM3 |
3.96882 |
[CC] GO:0098794 |
None
|
ADORA1, APP, DRD2, DRD4, GRIA2, GRIA4, GRM3 |
3.82853 |
[CC] GO:0120025 |
None
|
ADORA1, AKR1B1, APP, CA2, CHRM1, CHRM2, CHRM3, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, SLC6A2, SLC6A3, SRC |
3.67642 |
[CC] GO:0031224 |
None
|
ACHE, ADORA1, ADORA3, APP, AXL, CA12, CA14, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, DRD2, DRD3, DRD4, ESR1, F10, FLT3, FUT7, GRIA2, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD11B1, HSD17B2, IGF1R, KDR, MET, SLC1A1, SLC6A2, SLC6A3, TYR |
3.50277 |
[CC] GO:0042734 |
None
|
GRIK5, GRM1, GRM3, GRM5, GRM8 |
3.50277 |
[CC] GO:0043197 |
None
|
ADORA1, APP, DRD2, GRIA2, GRIA4, GRM3 |
3.38278 |
[CC] GO:0097458 |
None
|
ADORA1, APP, CA2, CHRM1, CHRM2, CHRM3, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, SLC6A2, SLC6A3, SRC |
3.36717 |
[CC] GO:0044309 |
None
|
ADORA1, APP, DRD2, GRIA2, GRIA4, GRM3 |
3.35355 |
[CC] GO:0044463 |
None
|
ADORA1, AKR1B1, APP, CA4, CA9, CHRM1, CHRM2, CHRM3, DRD2, GRIA2, GRIA4, GRIK5, GRM3, SRC |
2.95977 |
[CC] GO:0120038 |
None
|
ADORA1, AKR1B1, APP, CA4, CA9, CHRM1, CHRM2, CHRM3, DRD2, GRIA2, GRIA4, GRIK5, GRM3, SRC |
2.95977 |
[CC] GO:0045202 |
None
|
ACHE, APP, CHRM1, CHRM2, CHRM3, CHRM5, GRIA2 |
2.59774 |
[CC] GO:0016021 |
None
|
ADORA1, ADORA3, APP, AXL, CA12, CA14, CA9, CHRM1, CHRM2, CHRM3, CHRM5, DRD2, DRD3, DRD4, ESR1, FLT3, FUT7, GRIA2, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD11B1, HSD17B2, IGF1R, KDR, MET, SLC1A1, SLC6A2, SLC6A3, TYR |
2.55012 |
[CC] GO:0043679 |
None
|
CHRM1, CHRM2, CHRM3, DRD2 |
2.53097 |
[CC] GO:0044306 |
None
|
CHRM1, CHRM2, CHRM3, DRD2 |
2.21031 |
[CC] GO:0030425 |
None
|
CHRM1, CHRM2, CHRM3, DRD2, GRIA2, GRIK5, GRM1 |
2.0917 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
2.03121 |
[MF] GO:0030594 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, DRD2, DRD3, DRD4, GRIA2, GRIA4, GRIK5, GRM1, GRM5 |
10.6331 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
9.87195 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD2, DRD3, DRD4, ESR1, ESR2, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, PPARA, RORC |
9.27139 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, TYR, XDH |
8.95072 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD2, DRD3, DRD4, ESR1, ESR2, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, PPARA, RORC |
8.46745 |
[MF] GO:0008066 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
8.29009 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD2, DRD3, DRD4, ESR1, ESR2, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, PPARA, RORC |
8.21618 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD2, DRD3, DRD4, ESR1, ESR2, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, PPARA, RORC |
7.71146 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD2, DRD3, DRD4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET |
7.23119 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD2, DRD3, DRD4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET |
7.23119 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, F10, FABP3, FABP4, FDPS, FLT3, HMGCR, HSD17B1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A3, SRC, TYR, XDH |
6.71277 |
[MF] GO:0016907 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
6.43795 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.3974 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
5.56649 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CDC25B, CHRM1, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F10, FDPS, FLT3, FUT7, HMGCR, HSD11B1, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PTPN1, SRC, TYR, XDH |
5.45611 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, CBR1, HMGCR, HSD11B1, HSD17B1, HSD17B2, XDH |
5.17103 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, F10, FDPS, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A3, TYR, XDH |
5.04812 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, FLT3, IGF1R, KDR, MET, PIM1, PPARA, SLC6A3, SRC |
5.02995 |
[MF] GO:0035240 |
None
|
DRD2, DRD3, DRD4, SLC6A3 |
4.63183 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HMGCR, HSD11B1, HSD17B1, HSD17B2, TYR, XDH |
4.47467 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, CBR1, HMGCR, HSD11B1, HSD17B1, HSD17B2 |
4.4053 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, CHRM3, DRD2, DRD3, DRD4, SLC6A3 |
4.37183 |
[MF] GO:0015464 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
4.12861 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, MMP1, MMP2, MMP9, PPARA, PTPN1, RORC |
4.02497 |
[MF] GO:1901338 |
None
|
DRD2, DRD3, DRD4, SLC6A3 |
3.97534 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.75556 |
[MF] GO:0004930 |
None
|
ADORA1, ADORA3, CHRM1, CHRM2, CHRM3, CHRM5, DRD2, DRD3, DRD4, GRM1, GRM3, GRM5, GRM8, HCAR2 |
3.71991 |
[MF] GO:0008227 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, DRD2 |
3.63532 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.57285 |
[MF] GO:0001591 |
None
|
DRD2, DRD3, DRD4 |
3.5172 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.50277 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
3.38278 |
[MF] GO:0004629 |
None
|
ADORA1, CHRM1, CHRM3, CHRM5 |
3.37097 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.08499 |
[MF] GO:0004952 |
None
|
DRD2, DRD3, DRD4 |
3.04935 |
[MF] GO:0099528 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.04702 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.93786 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, F10, FDPS, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A3, TYR, XDH |
2.90772 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
2.80565 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, XDH |
2.78642 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR |
2.77567 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, PPARA, RORC |
2.68615 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, PPARA, RORC |
2.68615 |
[MF] GO:0005330 |
None
|
SLC6A2, SLC6A3 |
2.55012 |
[MF] GO:0099583 |
None
|
GRM1, GRM5 |
2.55012 |
[MF] GO:0004970 |
None
|
GRIA2, GRIA4, GRIK5 |
2.54456 |
[MF] GO:0005234 |
None
|
GRIA2, GRIA4, GRIK5 |
2.54456 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.54456 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, PPARA, RORC |
2.43617 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.31932 |
[MF] GO:0004971 |
None
|
GRIA2, GRIA4 |
2.31932 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC |
2.28552 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, APP, CSNK2A1, DRD2, DRD4, ESR1, ESR2, FLT3, GRIK5, HMGCR, IGF1R, KDR, MET, MMP9, TYR, XDH |
2.22832 |
[MF] GO:0004435 |
None
|
CHRM1, CHRM3, CHRM5 |
2.18328 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD17B1, HSD17B2 |
2.18328 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC |
2.17109 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.15816 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, CSNK2A1, FLT3, IGF1R, KDR, MMP9, PIM1, PPARA, PTPN1, SLC6A3, SRC |
2.15143 |
[MF] GO:0051721 |
None
|
HMGCR, PTPN1, SLC6A3 |
2.14981 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD17B1, HSD17B2 |
2.11881 |
[MF] GO:0005158 |
None
|
IGF1R, PTPN1, SRC |
2.04916 |
[MF] GO:0005329 |
None
|
SLC6A2, SLC6A3 |
2.03121 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.03121 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR |
2.00302 |